MENU
+Compare
PTCHF
Stock ticker: OTC
AS OF
Jul 21 closing price
Price
$1.77
Change
+$0.06 (+3.51%)
Capitalization
442.07M

PTCHF PureTech Health PLC Forecast, Technical & Fundamental Analysis

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system... Show more

PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PTCHF with price predictions
Jul 21, 2025

PTCHF's RSI Oscillator leaves overbought zone

The 10-day RSI Indicator for PTCHF moved out of overbought territory on July 15, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 instances where the indicator moved out of the overbought zone. In of the 25 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where PTCHF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 09, 2025. You may want to consider a long position or call options on PTCHF as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PTCHF just turned positive on July 21, 2025. Looking at past instances where PTCHF's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

PTCHF moved above its 50-day moving average on July 09, 2025 date and that indicates a change from a downward trend to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 163 cases where PTCHF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.025) is normal, around the industry mean (18.131). P/E Ratio (8.429) is within average values for comparable stocks, (58.574). PTCHF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.444). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (105.263) is also within normal values, averaging (274.844).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly better than average price growth. PTCHF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PTCHF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
6 Tide Street
Phone
+1 617 482-2333
Employees
111
Web
https://www.puretechhealth.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGQRX17.430.03
+0.17%
Virtus KAR Global Quality Dividend R6
PCCGX11.46N/A
N/A
Victory Pioneer Mid Cap Value C
FTCHX66.82-0.04
-0.06%
Invesco Technology Investor
PEUCX39.69-0.05
-0.13%
Principal Equity Income C
ADNCX19.57-0.20
-1.01%
American Beacon ARK Transfmt Innov C

PTCHF and Stocks

Correlation & Price change

A.I.dvisor tells us that PTCHF and PHGE have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTCHF and PHGE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCHF
1D Price
Change %
PTCHF100%
+3.51%
PHGE - PTCHF
22%
Poorly correlated
+3.64%
BCTX - PTCHF
22%
Poorly correlated
+0.59%
ACET - PTCHF
20%
Poorly correlated
-2.57%
SBMFF - PTCHF
18%
Poorly correlated
-4.35%
RVXCF - PTCHF
10%
Poorly correlated
+8.50%
More